(Q38179853)

30 August 2017

title

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms (English)

1 reference

World Health Organization

30 August 2017

main subject

0 references

0 references

1

A Tefferi

1 reference

30 August 2017

J Thiele

2

1 reference

30 August 2017

A M Vannucchi

series ordinal

3

1 reference

30 August 2017

T Barbui

series ordinal

4

1 reference

30 August 2017

publication date

20 January 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

28

1 reference

30 August 2017

issue

7

1 reference

30 August 2017

page(s)

1407-1413

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2014.35

30 August 2017

exact match

0 references

cites work

Concomitant occurrence of BCR-ABL and JAK2V617F mutation

1 reference

12 December 2020

Somatic mutations of calreticulin in myeloproliferative neoplasms

1 reference

12 December 2020

Masked polycythemia vera (mPV): results of an international study

1 reference

12 December 2020

Bone marrow histopathology in chronic myelogenous leukemia (CML)--evaluation of distinctive features with clinical impact

1 reference

12 December 2020

Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study

1 reference

12 December 2020

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

1 reference

12 December 2020

Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS.

1 reference

12 December 2020

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

1 reference

12 December 2020

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

1 reference

12 December 2020

Mutations and prognosis in primary myelofibrosis

1 reference

12 December 2020

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

12 December 2020

Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay

1 reference

12 December 2020

Personalized management of essential thrombocythemia-application of recent evidence to clinical practice

1 reference

12 December 2020

An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia

1 reference

12 December 2020

The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy

1 reference

12 December 2020

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

1 reference

12 December 2020

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

1 reference

12 December 2020

Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia

1 reference

12 December 2020

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

1 reference

12 December 2020

Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.

1 reference

12 December 2020

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

1 reference

12 December 2020

Cardiovascular events and intensity of treatment in polycythemia vera

1 reference

12 December 2020

Rethinking the diagnostic criteria of polycythemia vera

1 reference

12 December 2020

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

1 reference

12 December 2020

Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease

1 reference

12 December 2020

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML

1 reference

12 December 2020

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

1 reference

12 December 2020

NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement

1 reference

12 December 2020

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

1 reference

12 December 2020

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

12 December 2020

The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition

1 reference

12 December 2020

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

1 reference

12 December 2020

Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia

1 reference

12 December 2020

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.

1 reference

12 December 2020

An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia

1 reference

12 December 2020

Calreticulin is essential for cardiac development

1 reference

12 December 2020

BCR-ABL transcripts may be detected in essential thrombocythemia but lack clinical significance

1 reference

12 December 2020

Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia.

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2014.35

1 reference

Dimensions Publication ID

30 August 2017

1027744616

0 references

1 reference